These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3809187)

  • 1. Policy on monitoring and reporting results.
    Louis TA; Bouffioux C; Tazaki H; Acosta-Otero A; Khoury S; Kopp J; Mazeman E; Obata K; Tagnon H; Wittes RE
    Prog Clin Biol Res; 1986; 221():33-48. PubMed ID: 3809187
    [No Abstract]   [Full Text] [Related]  

  • 2. Standardization of format of reporting results.
    Dalesio O; Barton B; Hisazumi H; Hilgar A; Staquet M; Tagnon H; Uyama T
    Prog Clin Biol Res; 1986; 221():15-31. PubMed ID: 3809181
    [No Abstract]   [Full Text] [Related]  

  • 3. Statistical analysis techniques and sample size determination for clinical trials of treatments for bladder cancer.
    Byar D; Kaihara S; Sylvester R; Freedman L; Hannigan J; Koiso K; Oohashi Y; Tsugawa R
    Prog Clin Biol Res; 1986; 221():49-64. PubMed ID: 3809188
    [No Abstract]   [Full Text] [Related]  

  • 4. Standardization of protocol format.
    Sylvester R; Griffin P; Koiso K; Hilgar A; Kumazawa J; Matsumura Y
    Prog Clin Biol Res; 1986; 221():3-13. PubMed ID: 3809186
    [No Abstract]   [Full Text] [Related]  

  • 5. Bladder-sparing procedure as good as cystectomy for treating invasive bladder cancer.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):7-9. PubMed ID: 12553324
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Trials Referral Resource. Clinical trials in bladder and urothelial cancers.
    Kaplan RS; Cheson BD; Nelson AP
    Oncology (Williston Park); 1997 Sep; 11(9):1348, 1351. PubMed ID: 9306423
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials referral resource. Bladder cancer.
    Cheson BD
    Oncology (Williston Park); 1992 Jan; 6(1):105-6. PubMed ID: 1531596
    [No Abstract]   [Full Text] [Related]  

  • 8. Open clinical uro-oncology trials in Canada.
    Mackenzie MJ; Rodrigues G; Winquist E
    Can J Urol; 2009 Jun; 16(3):4706-11. PubMed ID: 19497189
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines and trials.
    Klotz LH
    Can J Urol; 2002 Oct; 9(5):1623. PubMed ID: 12431322
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the possibilities of improving recovery results in bladder cancer].
    Karcher G
    Med Welt; 1965 Sep; 38():2148-52. PubMed ID: 5862862
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravesical BCG for bladder cancer: how much is enough?
    Kamat AM
    Cancer; 2008 Aug; 113(4):674-6. PubMed ID: 18543323
    [No Abstract]   [Full Text] [Related]  

  • 12. BCG in the management of superficial bladder cancer.
    Robinson MR
    Prog Clin Biol Res; 1985; 185B():161-6. PubMed ID: 3898140
    [No Abstract]   [Full Text] [Related]  

  • 13. [Robust analysis methods for multivariate survival times].
    Lancar R
    Rev Epidemiol Sante Publique; 1999 Jun; 47(3):287-96. PubMed ID: 10422122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials in superficial and invasive bladder cancer.
    Smith PH
    Turk J Pediatr; 1984; 26(1-4):251-63. PubMed ID: 6443168
    [No Abstract]   [Full Text] [Related]  

  • 15. When and how to treat superficial and muscle-invasive bladder cancer.
    Zlotta AR
    Eur Urol; 2007 Dec; 52(6):1554-7. PubMed ID: 17904728
    [No Abstract]   [Full Text] [Related]  

  • 16. Methodology of superficial bladder cancer trials: objective evaluation of treatment - the need for standardization.
    Bassi PF; Volpe A; Racioppi M; D'Agostino D; Gardi M; Totaro A; Pinto F; Sacco E; Bongiovanni L
    Urol Int; 2009; 83(3):258-63. PubMed ID: 19829021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for novel therapeutics and targets: insights from clinical trials.
    Mitra AP; Cote RJ
    Urol Oncol; 2007; 25(4):341-3. PubMed ID: 17628305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Active studies on bladder carcinoma in the year 2004].
    Rexer H
    Urologe A; 2004 Mar; 43(3):318-20. PubMed ID: 15045194
    [No Abstract]   [Full Text] [Related]  

  • 19. BCG immunotherapy in superficial cancer of the bladder.
    Levinson IP; van Blerk PJ
    S Afr J Surg; 1985 Jun; 23(2):53-4. PubMed ID: 3895464
    [No Abstract]   [Full Text] [Related]  

  • 20. [Kinetic criteria on the effectiveness of treatment of bladder cancer in humans].
    Emanuél' NM; Barsel' VA; Bulaevskiĭ LN; Evseenko LS
    Dokl Akad Nauk SSSR; 1967 Feb; 172(4):988-91. PubMed ID: 5622363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.